Early Career Scientist Speed Mentoring Event

Early Career Scientist Speed Mentoring Event

Thursday, Nov. 7, 2024  |  8:30 p.m.–9:30 p.m. CST*  |  Event Full

Marriott Marquis Houston Downtown - Level 3

*Times and program schedule subject to change. SITC membership is required for participation in the ECS Speed Mentoring event.
For additional questions, please contact Renee Reyes at rreyes@sitcancer.org.

Program Organizers

  • Ardit Feinaj, MD – Johns Hopkins University
  • Robyn Gartrell, MD – Johns Hopkins University
  • Sarah Gitto, PhD – University of Pennsylvania
  • Tanya Keenan, MD, MPH – Merck Research Laboratories
  • Ashley Koegel, MD – Bristol Myers Squibb
  • Daniel Michaud, PhD – Brigham & Women’s Hospital
  • Abdul Rafeh Naqash, MD – Stephenson Cancer Center, Oklahoma University
  • Abigail Overacre-Delgoffe, PhD – University of Pittsburgh
  • Quaovi Sodji, MD, PhD – University of Wisconsin-Madison 

 

Program Description

The ECS Speed Mentoring Event will provide early career scientists the opportunity to receive mentorship from an expert in the field of cancer immunotherapy in a one-on-one setting. Hosted by SITC's Early Career Scientist Committee, mentees will be matched with an expert mentor allowing time for a discussion with an expert mentor. Also, during this event we will provide an opportunity for networking in an adjoining area. Mentees are required to indicate interest to attend this event when registering for SITC's annual meeting. Mentees are selected on a first come first serve basis and will be contacted for participation. 

Target Audience

The audience for the ECS Speed Mentoring Event includes Students and Scientists-in-Training who are seeking one-on-one career mentorship from experts in the field of cancer immunotherapy. Clinical fellows and clinical residents are also welcome to apply for this event. All mentees should be prior to assistant professorship. SITC membership is required for participation in the ECS Speed Mentoring event. Click here to become a member.

Mentorship Topics

  • Basic/Translational Science

    • Niroshana Anandasabapathy, MD, PhD – Weill Cornell Medicine

    • Riyue Bao, PhD – UPMC Hillman Cancer Center

    • Tullia Bruno, PhD –  University of Pittsburgh

    • Greg Delgoffe, PhD – University of Pittsburgh

    • Sandra Demaria, MD – Weill Cornell Medicine

    • Olivera Finn, PhD, FAIO – University of Pittsburgh

    • Patrick Hwu, MD – Moffitt Cancer Center

    • Elizabeth Jaffee, MD, FAIO – Sidney Kimmel Cancer Center/Johns Hopkins University

    • Christopher Johnston, PhD – Fred Hutchinson Cancer Center

    • Nikhil Joshi, PhD – Yale School of Medicine

    • Lewis Lanier, PhD – University of California, San Francisco

    • Andy Minn, MD, PhD – University of Pennsylvania

    • Daniel Powell, PhD – University of Pennsylvania

    • Sergio Quezada, PhD – University of College London

    • Jeffrey Rathmell, PhD – Vanderbilt University Medical Center

    • Stephen Schoenberger, PhD – La Jolla Institute for Immunology

  • Clinician Scientists Academia

    • Diwakar Davar, MD – University of Pittsburgh Medical Center/Hillman Cancer Center

    • Sangeeta Goswami, MD, PhD – University of Texas MD Anderson Cancer Center

    • Thomas Marron, MD, PhD – Mount Sinai

    • Marco Ruella, MD – University of Pennsylvania 

  • Government Jobs

    • Stephanie Goff, MD, PhD – National Cancer Institute

    • James Gulley, MD, PhD – National Cancer Institute

  • Industry: Non-Lab-Based

    • Ivan Diaz-Padilla, MD, PhD – GSK

    • Friedrich Finckenstein, MD – Iovance Biotherapuetics

    • Ezo Gruyters, PhD – AstraZeneca

    • Parameswaran Hari, MD – Obsidian Therapeutics

    • Kristen Hege, MD

    • Stephen Lim, MD – Novartis

    • Pablo Martinez, MD, PhD – Amgen

    • Giovanni Melillo, MD – AstraZeneca

    • Jon Wiggington, MD – Bright Peak Therapeutics

  • Industry: Research and Development/Translational

    • Lisa Butterfield, PhD – Merck

    • Daniel Chen, MD, PhD – Synthetic Design Lab

    • Guy Clifton, MD – Incendia Therapeutics

    • Leisha Emens, MD, PhD – Ankyra Therapeutics

    • Howard Kaufman, MD – Ankyra Therapeutics

    • Akshay Krishnamurty, PhD – Genentech, Inc.

    • Gordan Moody, PhD – AstraZeneca

  • Industry: Start-Up and Biotech

    • Rachel Humphrey, MD – Normunity, Inc.

    • Johanna Kaufman, PhD

    • Francesco Marincola, MD – Sonata

    • Arvind Natarajan, PhD – Iovance

    • Zhen Su, MD, MBA – Marengo Therapeutics

    • Dario Vignali, PhD – University of Pittsburgh

MTE_1.jpg
MTE_2.jpg